BGI Genomics Dividends and Buybacks
Dividend criteria checks 0/6
BGI Genomics is a dividend paying company with a current yield of 0.23%.
Key information
0.2%
Dividend yield
0%
Buyback Yield
| Total Shareholder Yield | 0.2% |
| Future Dividend Yield | 0.2% |
| Dividend Growth | 22.0% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥0.100 |
| Payout ratio | -40% |
Recent dividend and buyback updates
Recent updates
Is BGI Genomics (SZSE:300676) Using Too Much Debt?
Oct 22
BGI Genomics Co., Ltd. (SZSE:300676) Held Back By Insufficient Growth Even After Shares Climb 31%
Oct 01Is BGI Genomics (SZSE:300676) A Risky Investment?
Jul 15Why Investors Shouldn't Be Surprised By BGI Genomics Co., Ltd.'s (SZSE:300676) Low P/S
May 22BGI Genomics' (SZSE:300676) Conservative Accounting Might Explain Soft Earnings
Apr 21Here's Why BGI Genomics (SZSE:300676) Can Manage Its Debt Responsibly
Mar 25Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 300676 is not paying a notable dividend for the CN market, therefore no need to check if payments are stable.
Growing Dividend: 300676 is not paying a notable dividend for the CN market, therefore no need to check if payments are increasing.
Dividend Yield vs Market
| BGI Genomics Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (300676) | 0.2% |
| Market Bottom 25% (CN) | 0.5% |
| Market Top 25% (CN) | 2.1% |
| Industry Average (Biotechs) | 1.3% |
| Analyst forecast (300676) (up to 3 years) | 0.2% |
Notable Dividend: 300676's dividend (0.23%) isn’t notable compared to the bottom 25% of dividend payers in the CN market (0.55%).
High Dividend: 300676's dividend (0.23%) is low compared to the top 25% of dividend payers in the CN market (2.12%).
Earnings Payout to Shareholders
Earnings Coverage: 300676 is not paying a notable dividend for the CN market.
Cash Payout to Shareholders
Cash Flow Coverage: 300676 is paying a dividend but the company has no free cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/25 12:59 |
| End of Day Share Price | 2024/12/25 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
BGI Genomics Co., Ltd. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yiling Chen | Guosen Securities Co., Ltd. |
| Hanqing Zhu | Guosen Securities Co., Ltd. |
| Jiaxi Xu | Industrial Securities Co. Ltd. |